Bambusa Therapeutics climbs 3% to 52-week high

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Bambusa Therapeutics (BBTX.US) climbed more than 3% during regular trading to $17.49, hitting a 52-week high intraday.

Peter Kolchinsky and Rajeev Shah disclosed on Nov. 6 that they hold a 14.6% stake in the company. On the same day, Bambusa completed an oversubscribed initial public offering at $16 per share, raising $169 million.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings